Bustamante, Regine Fher S.
HRN: 21-22-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2024
CEFTRIAXONE 1G (VIAL)
07/30/2024
08/05/2024
IV
1.1g
OD
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes